Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My little bit is locked, don't know if it makes a difference but...ONCI!
Wow! Just occurred to me, someone sold their 28 mil shares at a profit yesterday and now today wants the rest of the investors to loose money? Wow, It really is the Old West! LOL
GO ONCI!
Do you have information on that name change that is not common knowledge?
Seems to want to hang out about .006, I'm hoping to see .007 EOD. Go ONCI!
My guess (thats all it is) is that they will be announced after the name change. Why sign contracts now as ONCI only to have o change everything soon.
Me! I'm looking for a Good Friday! GREEN finish. What do you suppose the T-Trade last night meant? What was it....1.8 mil buy at .0064?
Go ONCI!
T-Trade. 1.8 mil, Buy. @.0064
It's a shame all of this finger pointing at the CEO When even I can see it is not him to blame. Am I happy at present, no, am I selling, no, why? I see no trace of scam in SB's past but I do see success and leopards do not change their spots. What I see is this situation hinges on the Name change, no one is dealing with ONCI, including SB, they are waiting on the name change. When it comes, CO move can be made, contracts will be signed, agreements made, shipments sent and PR announcements made! And yes there are other things at work here also, clearing any final debt before the change as announced, possible financing for other arms (MMJ). Until then, this is what we have for a while longer. We are very close to the name change now, in my opinion, the dark before the dawn. Me, I'm waiting for the bottom, then I'll jump in and average way down.
SB made one promise in his last tweets, I plan on being here to see him keep it.
JMHO GLTA ONCI
Some people bought into the NECA stock, now that it is worthless they are hoping to pump it up enough to get out.
There's your T trade, 1,800,000
Oops and a second 653K
Both pretty small compared to what we have seen.
Wrong, go back tot he CC and listen again, listen to the whole sentence and you will hear that he ended it with "I HOPE." No promise was make, only his hopes.
No, actually he did not promise that, to anyone.
No house was ever promised anyone.
Please quit spamming the ONCI board with neca nonsense.
Took me less than 15 sec. to find it on google.
LOL! Good luck to you.
No more. Time for this to give back a bit.
LOL! No way!
Correct me if I'm wrong but I seem to remember that it was Plpl that applied for the SA MMJ license, not TXTM.
What is this suppose to prove? No name, No signature, expired in 2014? What does this have to do with ONCI Stocks?
Here you go, from the past, it clears it up.
$Pistol Pete$ Member Level Wednesday, 03/08/17 10:41:20 PM
Re: None
Post # of 13214
$PLPL Plandai Biotechnology Announces Share Exchange Between Protext Mobility and Plandai's South Africa Subsidiary
Source: InvestorsHub NewsWire
Plandai Biotechnology, Inc.
Plandai South Africa Will Operate Independent From Plandai Parent and Focus on Pharmaceutical Application Research
BOCA RATON, FL--(NewMediaWire - Jan 10, 2017) - Plandaí Biotechnology, Inc. (OTC PINK: PLPL) ("Plandaí" or "the Company"), producer of the highly bioavailable Phytofare® catechin complex, today announced that it has completed a share exchange between Plandaí Biotechnology South Africa (PTY) LTD "Plandaí SA," and Protext Mobility, Inc. (OTC PINK: TXTM) "Protext", a Delaware company. Under the terms of the Exchange Agreement, Plandaí became the majority owner of Protext with Plandaí SA becoming the successor issuer to Protect for reporting and accounting purposes. It is anticipated that the prior operations and assets of Protext will be liquidated in the coming weeks, leaving Plandaí SA as the surviving operating entity.
Plandaí SA was established in 2014 by Plandaí Biotechnology, Inc. to provide a platform for expanding the research of Plandaí's proprietary Phytofare® extracts into pharmaceutical application and then obtaining product claims. Phytofare® has been clinically proven in human studies to provide ten times greater bioavailability, which is the ability of the body to absorb the nutrients, over generic plant extracts. The first product brought to market, Phytofare® catechin complex, is derived from green tea and contains all eight catechins in a highly absorbable biocompatible structure. Where the parent company, Plandaí Biotechnology, focuses on selling Phytofare® as an ingredient to manufacturers in the nutraceutical industry, Plandaí SA will target the pharmaceutical market with a finished product.
Plandaí SA has the exclusive license and rights to develop, manufacture, and sell all current and future Phytofare® extracts for the pharmaceutical market worldwide. The first targeted product will focus on treating diabetes by regulating blood sugar levels with an expectation of being market ready by the latter half of 2017.
Roger Baylis-Duffield, Chief Executive Officer of Plandaí, commented, "This strategic moves allows us to separate the research component of our business into a separate, self-funding entity, freeing up Plandaí to focus on Phytofare® manufacture and sales. Plandaí SA will operate with distinct management concentrating on pharmaceutical applications and obtaining drug and structure-function claims. Where Plandaí produces and sells an ingredient to the nutraceutical industry, Plandaí SA will produce a finished product targeting a specific application, such as managing glucose levels in diabetics."
About Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc (OTC PINK: PLPL). and its subsidiaries develop highly bioavailable extracts. It controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare® extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include cosmeceutical, wellness, anti-aging, pharmaceutical and animal husbandry.
For more information, please visit http://www.plandaibiotech.com.
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at http://www.sec.gov.
I have wondered this myself, my guess is it would be TXTM but If I read correctly it is PLPL that actually gets the license, correct?
I seem to remember it being pointed out that it was a timing matter. the Share reduction was announced prior to any knowledge of the other deals that came, such as the possible need for additional production lines due to the deals made in Dubai. When I listen to the CC, I understood that that additional dilution may be needed based on current events. Your thoughts?
Insta, If you don't mind, I would like to be added to the PM list.
OK, I'm confused, why go through the process of registering ONCI?
That was the solution the CEO offered to all in doubt. For myself, IF I had half of the doubt level expressed, I would have sold @ -10% and never looked back. Actually, For someone to doubt so much and yet be here this long shows a lot of faith in Mr.B as a Legit CEO.
JMO ONCI
Then again, It is equally possible , since you offer no verifiable third party evidence to the contrary, that this is indeed legit and valid. That is JMO which holds as much value as your opinion.
Look again KW. I'm wondering what ONCI will do this Friday's PH. being the 1st day of a new month.
Ok, help me out please. I hear all of this about Shares being retired and then dilution of the shares.
I understood that Mr. B Retired a very large portion of his personal shares paid to him as part of an agreement for his services.
Isn't that a bit unusual? It would seem to me that most CEO's would cash in on that to get the money, not retire the opportunity.
Next, Did I missunderstand in the CC that there may be dilution coming, (I take this in context what he was speaking on at the time)
That this came about due to developments that came to past after the share retirement announcement? In light of his CC I understood that dilution may be needed to to finance a possible investment in a MMJ company and or adding on more production lines for the app due to possible large demand from the Dubai meeting? If I'm not missunderstanding these things, Would this not be a good thing for the company?
Still learning so any help is appreciated. ONCI
I seem to recall our CEO offering a fix for you to all of this.
Actually I have done my DD and continue to do so. To date I find no evidence of a true scam here or in Mr.B's past. The fact that he left TXTM speaks positive volumes to me. I can not deny that these pps have rattled me a bit but It has not caused me to loose faith in our CEO, rather I wonder if there isn't something else working against this. That said I actually see Our CEO trying his best to appease (even though he is not obligated to do so) the share holders with what information that he legally can share, only to be slammed for it. I still believe in SB and ONCI.
But this is Just My humble opinion.
Because some time back he was the interim CEO of TXTM and was on the board PLPL. I understand that he left for ethical reasons. Pretty certain it is an outdated email.
Love the new look!
Been seeing them but 70k is pretty small compared to what has been coming in, also at the share price, seems unusual compared to what we have been seeing.
Kind of wondering.
I picked up another 50K at 0.0081 this morning.
Yes I am. As I have read, PLPL and Cannabis biosciences are both wholy owned subsidiaries of TXTM. Some of what I was reading seems to have disappeared since PLPL became inactive. But there are interesting things there.
Do you know why it will run?
OK a question, WHY would people be buying our Subsidiary plpl shares when it has been declared inactively the SEC?
I would venture that several loaded up Wed. and Fri. @ the low .009's and now the cycle begins again. Either way, it's more eyes on ONCI!
Seriously Why are you expecting? Or do you mean hoping? If so, I'm with you!